03:45 PM EST - Valeant Pharmaceuticals International, Inc. : Announced new fulfillment agreements with Walgreens while indicating it intends to extend this distribution model to additional participating independent retail pharmacies. In conjunction with the fulfillment agreement, Valeant will reduce prices of its branded prescription-based dermatological and ophthalmological products by 10%. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $20.02 at $149.26.
